FindTrial
Sign In

Agreement of the probe which measures surface changes using electrical property with colposcopy to identify pre cancer lesions in cervix

Concordance of Electrical Impedance Spectroscopy with Standard colposcopy to detect cervical high grade lesions among screen positive patients -A Cross sectional analytical study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057932
Enrollment
171
Registered
2023-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R876- Abnormal cytological findings in specimens from female genital organs Health Condition 2: R878- Other abnormal findings in specimens from female genital organs Health Condition 3: R399- Unspecified symptoms and signs involving the genitourinary system

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL Control Intervention1: Electrical Impedance Spectroscopy: A device named ZedScan (based on Electrical Impedance Spectroscopy) is used to scan the cervix

Sponsors

Jawaharlal Institute of Postgraduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Abnormal Pap cytology or abnormal VIA/VILI positive or HPV DNA positive

Exclusion criteria

Exclusion criteria: 1.Post total hysterectomy patients 2.Menstruating at the time of visit 3.Pregnant at the time of visit 4.Active cervicitis or vulvovaginitis 5.Obvious growth in cervix suggestive of cancer 6.Unable to do low lithotomy position due to disease, disability or mental instability

Design outcomes

Primary

MeasureTime frame
Concordance between Eletrical Impedance Spectroscopy with Colposcopic Swede Score to detect high grade lesionsTimepoint: 2 years—

Secondary

MeasureTime frame
Proportion of high grade lesions detected by Electrical Impedance Spectroscopy and standard colposcopy to accurately diagnose preinvasive lesions CIN2/3Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Arpitha A

Jawaharlal Institute of Postgraduate Medical Education and Research

drarpithagynonco@gmail.com9481068681

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026